These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38451747)

  • 21. Investigating biological rhythms disruptions across the menstrual cycle in women with comorbid bipolar disorder and premenstrual dysphoric disorder.
    El Dahr Y; de Azevedo Cardoso T; Syan SK; Caropreso L; Minuzzi L; Smith M; Allega OR; El-Tayebani M; Mendes-Ribeiro J; de Mattos Souza LD; da Silva RA; Mondin TC; Moreira FP; Kapczinski F; Jansen K; Frey BN
    Arch Womens Ment Health; 2022 Apr; 25(2):345-353. PubMed ID: 35226173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attention, response inhibition, impulsivity, and decision-making within luteal phase in women with premenstrual dysphoric disorder.
    Yen JY; Lin PC; Hsu CJ; Lin C; Chen IJ; Ko CH
    Arch Womens Ment Health; 2023 Jun; 26(3):321-330. PubMed ID: 37010619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The late-luteal leptin level, caloric intake and eating behaviors among women with premenstrual dysphoric disorder.
    Ko CH; Yen CF; Long CY; Kuo YT; Chen CS; Yen JY
    Psychoneuroendocrinology; 2015 Jun; 56():52-61. PubMed ID: 25800149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadotrophic hormone and reinforcement sensitivity systems in women with premenstrual dysphoric disorder.
    Ko CH; Long CY; Yen CF; Chen CS; Wang PW; Yen JY
    Psychiatry Clin Neurosci; 2014 Nov; 68(11):785-94. PubMed ID: 24735107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to sertraline is associated with reduction in anxiety-potentiated startle in premenstrual dysphoric disorder.
    Hantsoo L; Grillon C; Sammel M; Johnson R; Marks J; Epperson CN
    Psychopharmacology (Berl); 2021 Oct; 238(10):2985-2997. PubMed ID: 34292344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Menstrual cycle effects on amygdala reactivity to emotional stimulation in premenstrual dysphoric disorder.
    Gingnell M; Morell A; Bannbers E; Wikström J; Sundström Poromaa I
    Horm Behav; 2012 Sep; 62(4):400-6. PubMed ID: 22814368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and correlates of current suicidal ideation in women with premenstrual dysphoric disorder.
    Wikman A; Sacher J; Bixo M; Hirschberg AL; Kopp Kallner H; Epperson CN; Comasco E; Sundström Poromaa I
    BMC Womens Health; 2022 Feb; 22(1):35. PubMed ID: 35148753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emotional fronto-cingulate cortex activation and brain derived neurotrophic factor polymorphism in premenstrual dysphoric disorder.
    Comasco E; Hahn A; Ganger S; Gingnell M; Bannbers E; Oreland L; Wikström J; Epperson CN; Lanzenberger R; Sundström-Poromaa I
    Hum Brain Mapp; 2014 Sep; 35(9):4450-8. PubMed ID: 24615932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facial emotion discrimination across the menstrual cycle in women with premenstrual dysphoric disorder (PMDD) and controls.
    Rubinow DR; Smith MJ; Schenkel LA; Schmidt PJ; Dancer K
    J Affect Disord; 2007 Dec; 104(1-3):37-44. PubMed ID: 17367867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Premenstrual appetite and emotional responses to foods among women with premenstrual dysphoric disorder.
    Yen JY; Liu TL; Chen IJ; Chen SY; Ko CH
    Appetite; 2018 Jun; 125():18-23. PubMed ID: 29407746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum brain-derived neurotrophic factor differences between the luteal and follicular phases in premenstrual dysphoric disorder.
    Oral E; Kirkan TS; Yildirim A; Kotan Z; Cansever Z; Ozcan H; Aliyev E; Gulec M
    Gen Hosp Psychiatry; 2015; 37(3):266-72. PubMed ID: 25799087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allopregnanolone Is Associated with a Stress-Induced Reduction of Heart Rate Variability in Premenstrual Dysphoric Disorder.
    Hamidovic A; Davis J; Soumare F; Naveed A; Ghani Y; Semiz S; Khalil D; Wardle M
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
    Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
    Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Historical sexual abuse and current thyroid axis profiles in women with premenstrual dysphoric disorder.
    Girdler SS; Thompson KS; Light KC; Leserman J; Pedersen CA; Prange AJ
    Psychosom Med; 2004; 66(3):403-10. PubMed ID: 15184704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder.
    Epperson CN; Pittman B; Czarkowski KA; Stiklus S; Krystal JH; Grillon C
    Neuropsychopharmacology; 2007 Oct; 32(10):2190-8. PubMed ID: 17314917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.
    Epperson CN; Haga K; Mason GF; Sellers E; Gueorguieva R; Zhang W; Weiss E; Rothman DL; Krystal JH
    Arch Gen Psychiatry; 2002 Sep; 59(9):851-8. PubMed ID: 12215085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temperature circadian rhythms during the menstrual cycle and sleep deprivation in premenstrual dysphoric disorder and normal comparison subjects.
    Parry BL; LeVeau B; Mostofi N; Naham HC; Loving R; Clopton P; Gillin JC
    J Biol Rhythms; 1997 Feb; 12(1):34-46. PubMed ID: 9104689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients reporting prospectively confirmed diagnosis with premenstrual dysphoric disorder.
    Eisenlohr-Moul T; Divine M; Schmalenberger K; Murphy L; Buchert B; Wagner-Schuman M; Kania A; Raja S; Miller AB; Barone J; Ross J
    BMC Psychiatry; 2022 Mar; 22(1):199. PubMed ID: 35303811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered visual cortex excitability in premenstrual dysphoric disorder: Evidence from magnetoencephalographic gamma oscillations and perceptual suppression.
    Manyukhina VO; Orekhova EV; Prokofyev AO; Obukhova TS; Stroganova TA
    PLoS One; 2022; 17(12):e0279868. PubMed ID: 36584199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daily symptom ratings for studying premenstrual dysphoric disorder: A review.
    Bosman RC; Jung SE; Miloserdov K; Schoevers RA; aan het Rot M
    J Affect Disord; 2016 Jan; 189():43-53. PubMed ID: 26406968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.